1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. ADMA BIOLOGICS INC
Adma Biologics Inc XNAS: ADMA

Adma Biologics Inc Live Stock Price Today, Share Analysis and Chart

Await Turnaround
about

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk f...

Read More
15.67 -0.16 (-1.01%)
38.96% Fall from 52W High
2.3M
XNAS Volume

XNAS 11 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Adma Biologics Inc is on 18 Mar 2026 for the purpose of ADMA Biologics Inc Annual Report for 2025 See details
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Mid Valuation
31.3 / 100
Momentum Score
Technically Neutral
41.6 / 100
Await Turnaround These stocks have poor financials and average valuation and momentum. Investors should be cautious about these stocks View Similar Embed DVM
Analyst Price Target
26
1Yr Price target upside is 64%
3 analysts

6

S

13

W

5

O

0

T

SWOT Analysis

Adma Biologics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..